Immunome Inc. (IMNM) awards RSUs and stock options to its CMO
Rhea-AI Filing Summary
Immunome Inc. granted Chief Medical Officer Robert Lechleider 54,000 RSUs and an employee stock option for 108,000 shares at a $22.01 exercise price on 2026-07-23. The RSUs vest 25% annually, while the options vest 25% on July 23, 2027 and monthly thereafter. After these awards he directly holds 69,805 common shares and 108,000 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 54,000 shares
Net Buy
2 txns
Insider
Lechleider Robert
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F2 | 108,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 54,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 108,000 shares (Direct);
Common Stock — 69,805 shares (Direct)
Footnotes (2)
- F1. Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date.
- F2. 25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Key Figures
RSUs granted: 54000.0000 shares
Options granted: 108000.0000 shares
Option exercise price: $22.0100 per share
+4 more
7 metrics
RSUs granted
54000.0000 shares
Restricted stock units granted on 2026-07-23
Options granted
108000.0000 shares
Employee stock option granted on 2026-07-23
Option exercise price
$22.0100 per share
Exercise price for 108,000-share employee stock option
Option expiration date
2036-07-22
Expiration of employee stock option grant
Shares held after RSU grant
69805.0000 shares
Direct common stock holdings following the RSU award
RSU annual vesting rate
25%
RSUs vest 25% annually on each anniversary of grant
Initial option cliff vesting
25% on 2027-07-23
First tranche of options vests one year after grant
Key Terms
restricted stock units ("RSUs"), Employee Stock Option, continuous service, vest and settle
4 terms
restricted stock units ("RSUs") financial
"underlying restricted stock units ("RSUs"). Each RSU represents the contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Employee Stock Option financial
"security_title": "Employee Stock Option (right to buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
continuous service financial
"subject to the Reporting Person's continuous service through each such vesting date"
vest and settle financial
"RSUs will vest and settle into Common Stock annually on each anniversary"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Immunome (IMNM) grant to CMO Robert Lechleider?
Immunome granted Robert Lechleider 54,000 restricted stock units and an employee stock option for 108,000 shares at a $22.01 exercise price. These awards were granted on July 23, 2026 and are reported as directly owned by him.
How do the RSUs granted to Immunome (IMNM) CMO vest?
The 54,000 RSUs vest and settle into common stock with 25% vesting annually on each anniversary of the July 23, 2026 grant date, subject to Robert Lechleider’s continuous service with Immunome through each applicable vesting date.
What is the vesting schedule for the 108,000 stock options reported by IMNM?
For the 108,000 stock options, 25% of the shares vest on July 23, 2027, and one-thirty-sixth of the remaining shares vest monthly thereafter. All vesting is conditioned on Robert Lechleider’s continuous service through each vesting date.
What is the exercise price and expiration date of the options in the IMNM Form 4?
The employee stock option has a $22.01 per-share exercise price and expires on July 22, 2036. It covers 108,000 shares of Immunome common stock, subject to the time-based vesting schedule described in the Form 4 footnotes.
Were the IMNM insider awards to Robert Lechleider made under a Rule 10b5-1 trading plan?
The Form 4’s Rule 10b5-1 checkbox is not marked, and the filing does not state that these equity awards were granted pursuant to a 10b5-1 trading plan. They are reported simply as compensation-related acquisitions.